Shoreline Biosciences has developed induced pluripotent stem cell (iPSC)-derived natural killer (NK) cells and macrophages that are optimized by applying gene editing to target specific genes with properties sought by the company. San Diego-based Shoreline says its “intelligently engineered” NK cells can target and kill tumors more effectively and efficiently…
[Full article text: https://www.genengnews.com/topics/drug-discovery/intelligent-cells-shoreline-builds-immunotherapy-platform-pipeline-with-140m-financing]